Skip to main content
FinSpry Logo
FinSpry
HRTX logo
HRTX
(NASDAQ)
Heron Therapeutics, Inc.
$0.80-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Heron Therapeutics (HRTX) Stock Price & Financial Analysis

Heron Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.77 - $0.81
52-Week High$2.61
52-Week Low$0.74
Open$0.79
Volume904.06K
Average Volume (3M)904.06K
Market Cap133.23M
Shares Outstanding166.71M
Price to Sales (P/S)0.86
Price to Book (P/B)9.35
EV/EBITDA-154.58
Revenue (TTM)154.90M
Net Income (TTM)-20.20M
Free Cash Flow (TTM)-27.91M
EPS (TTM)$-0.12
Profit Margin-13.04%
Operating Margin-1.64%
Return on Equity (ROE)-140.90%
Debt to Equity9.81
50-Day MA$1.10
200-Day MA$1.36
52-Week Change-61.92%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Heron Therapeutics

What is the current stock price for HRTX?

As of the latest trading session, HRTX stock trades at $0.80. The 52-week range is $0.74–$2.61, with a day range of $0.77–$0.81.

What is the P/E ratio for HRTX?

The P/E ratio (Price-to-Earnings) for HRTX is shown in the Key Statistics section. This valuation metric helps compare Heron Therapeutics, Inc. to industry peers.

Does HRTX pay dividends?

Heron Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HRTX?

Based on 1 analyst, the consensus for HRTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HRTX?

Heron Therapeutics's market capitalization is $133.2M, classifying it as a micro-cap company. Heron Therapeutics operates in the Healthcare sector within the Biotechnology industry.